C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2009
10/06/2009	US7598042 Early prostate cancer antigens (EPCA), polynucleotide sequences encoding them, and their use
10/06/2009	US7598041 HIV-1 VPR interactions with mitochondrial apoptosis inducing factor and methods of using the same
10/06/2009	US7597905 Hollow nanoparticle for use in the transfer of biopolymer into cells
10/06/2009	US7597904 casein-derived peptides obtained by hydrolysis of casein by a food grade bacteria containing Lactobacillus helveticusto provide a fermented dairy product containing metalloproteinases inhibitory agent
10/06/2009	US7597895 Peptide or antibody that competitively inhibits binding of CSP (competence signal peptide) to Streptococcus mutans histidine kinase; endocarditis
10/06/2009	US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma
10/06/2009	US7597888 nucleic acid molecules and polypeptide molecules that encode glycoprotein VI; modulating agents in regulating a variety of cellular processes
10/06/2009	CA2388811C Techniques for growth and differentiation of human pluripotent stem cells
10/06/2009	CA2376596C Humanized anti-erbb2 antibodies and treatment with anti-erbb2 antibodies
10/06/2009	CA2310888C Monoclonal human natural antibodies
10/06/2009	CA2296707C Increasing production of proteins in gram-positive microorganisms
10/06/2009	CA2248543C Directed switch-mediated dna recombination
10/06/2009	CA2245151C Improved process for obtaining insulin precursors having correctly bonded cystine bridges
10/06/2009	CA2167910C Aqueous multiple-phase isolation of polypeptide
10/06/2009	CA2159106C Human n-methyl-d-aspartate receptor subunits, nucleic acids encoding same and uses therefor
10/06/2009	CA2111205C Polypeptides having kinase activity, their preparation and use
10/01/2009	WO2009121055A1 Reduced dye probes for the detection of radical oxygen species
10/01/2009	WO2009120929A1 Method for amplifying locus in bacterial cell
10/01/2009	WO2009120611A2 Aldehyde tags, uses thereof in site-specific protein modification
10/01/2009	WO2009119794A1 Prophylactic/therapeutic agent for infectious disease
10/01/2009	WO2009119710A1 Novel antibiotic sf2896 substance, process for production thereof, and pharmaceutical composition
10/01/2009	WO2009119649A1 Kit for producing o-glycosylated protein in plant and use thereof
10/01/2009	WO2009119455A1 Cancer cell motility and cancer cell infiltration inhibitor
10/01/2009	WO2009118651A1 Host cells and methods of producing disulfide bond containing proteins
10/01/2009	WO2009117804A1 An anti-cancer cytotoxic monoclonal antibody
10/01/2009	WO2009086309A3 Cell culture processes
10/01/2009	US20090247733 Novel Bone Mineralization Proteins, DNA, Vectors, Expression Systems
10/01/2009	US20090247609 Sm-protein based secretion engineering
10/01/2009	US20090247482 50 Human Secreted Proteins
10/01/2009	US20090247460 Inhibitor of vascular endothelial cell growth factor
10/01/2009	US20090247456 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
10/01/2009	US20090246854 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same
10/01/2009	US20090246831 Using acid lysis to release translation products from cells
10/01/2009	US20090246830 Recombinant influenza viruses for vaccines and gene therapy
10/01/2009	US20090246829 Sequence analysis of the tetravalent rotavirus vaccine
10/01/2009	US20090246828 Arabinose Isomerase Expressed from Corynebacterium Genus and Tagatose Manufacturing Method by Using It
10/01/2009	US20090246827 Recombinant toxin fragments
10/01/2009	US20090246814 digestion of hemoglobin comprising a buffer, pepsin and a 1,3-dialkyl-imidazolium salt; for detecting HbA1c, and to a sampling tube for collection of a whole blood sample
10/01/2009	US20090246786 Novel rat voltage-gated potassium channel
10/01/2009	US20090246272 Mda-7 proteins and methods of use thereof
10/01/2009	US20090246228 Moraxella catarrhalis Proteins
10/01/2009	US20090246219 NOVEL SURFACE EXPOSED HAEMOPHILUS INFLUENZAE PROTEIN (PROTEIN E; pE)
10/01/2009	US20090246214 Fusion proteins containing recombinant cytotoxic rnases
10/01/2009	US20090246205 Inhibition of macrophage-stimulating protein receptor (ron)
10/01/2009	US20090246202 Human Endokine Alpha and Methods of Use
10/01/2009	US20090246201 Substances
10/01/2009	US20090246194 ERYTHROPOIETIN ANALOG-IgG FUSION PROTEINS
10/01/2009	US20090246192 1D05 PCSK9 antagonists
10/01/2009	US20090246191 Preparation of Purified Covalently Cross-linked Abeta Oligomers and Uses Thereof
10/01/2009	US20090246180 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/01/2009	US20090246132 Epitope bound by MAbs A, B, C or D, where MAbs A, B, C and D have given variable domains; chimeric or humanized for side effect reduction; polymerase chain reaction
10/01/2009	US20090246131 Production and Use of Novel Peptide-Based Agents for Use with Bi-Specific Antibodies
10/01/2009	US20090246129 Compositions and methods for the diagnosis and treatment of tumor
10/01/2009	CA2719559A1 Host cells and methods of producing disulfide bond containing proteins
10/01/2009	CA2719314A1 Method for amplifying locus in bacterial cell
10/01/2009	CA2712535A1 An anti-cancer cytotoxic monoclonal antibody
09/2009
09/30/2009	EP2105503A2 Method for the identification and isolation of binding polypeptides from combinatorial libraries of proteins having the scaffold structure of C-type lectin-like domains
09/30/2009	EP2105449A2 Antagonistic selective binding agents of osteoprotegerin binding protein
09/30/2009	EP2105446A2 Cytokine receptor zalpha11
09/30/2009	EP2104732A1 Cancerous disease modifying antibodies
09/30/2009	EP1789442B1 Muteins of fibroblast growth factor 21
09/30/2009	EP1678308B1 Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment
09/30/2009	EP1572971B1 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
09/30/2009	EP1465928B1 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies
09/30/2009	EP1451322B1 Il-21 antagonists
09/30/2009	EP1141297B1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them . uses
09/30/2009	EP0623168B1 T cell epitopes of the major allergens from dermatophagoides (house dust mite)
09/30/2009	CN101545001A Method for preparing swimbladder oligopeptide solution
09/30/2009	CN101545000A Method for improving yield of ECO-0501 produced by fermenting Amycolatopsis orientalis
09/30/2009	CN101544976A Bidirectional promoter bi-visual fluorescent protein report gene plant expression vector
09/30/2009	CN101544965A Coproduction process for extracting various bioactivators from pig placenta
09/30/2009	CN101544689A Leptospira vaccine candidate outer membrane protein
09/29/2009	US7595383 Secreted proteins of Mycobacterium tuberculosis and their use as vaccines and diagnostic reagents
09/29/2009	US7595379 Monoclonal antibody comprising an antigen binding site that binds specifically to PSCA protein wherein monoclonal antibody comprises the amino acid sequence of the variable heavy chain region and the variable light chain region of antibody secreted by hybridoma assigned A.T.C.C. Accession No.: PTA-6697
09/29/2009	US7595378 Can be produced by a transfectoma or in a non-human transgenic animal
09/29/2009	US7595376 Poly zinc finger proteins with improved linkers
09/29/2009	US7595191 Expression and purification of a recombinant Plasmodium falciparum (3D7) MSP-142; produces a highly purified protein which retains folding and disulfide bridging of the native molecule; vaccine for malaria
09/29/2009	US7595184 Nitrile hydratase variant
09/29/2009	US7595182 Endoglucanase STCE and cellulase preparation containing the same
09/29/2009	US7595181 From thermophilic microorganisms; active at high temperature
09/29/2009	US7595174 Mutating one or more of the cysteine residues in the polynucleotide sequences encoding the mature proteins which has antihepatitis activity
09/29/2009	US7595173 Producing antimicrobial peptides (AMPs) by using microbes; not necessary to offset the positive charges of multiple copies of AMPs in multimeric constructs; enables the use of a wider range of multimers and carrier peptides
09/29/2009	US7595059 Diagnosis of cysticercosis; immunoassay
09/29/2009	US7595058 Chlamydia antigens and vaccine uses of the protein
09/29/2009	US7595057 Streptococcus pyogenes antigens and corresponding DNA fragments
09/29/2009	US7595051 Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies
09/29/2009	US7595049 Monoclonal antibody for prevention and treatment of human immunodeficiency viral infection; immunotherapy
09/29/2009	US7595044 Artery-and vein-specific proteins and uses therefor
09/29/2009	CA2425852C Cytomegalovirus intron a fragments
09/29/2009	CA2404163C Production of recombinant blood clotting factors in human cell lines
09/29/2009	CA2322052C Calcium salts of lipopeptide antibiotics, method for producing same and their use
09/29/2009	CA2240737C A long qt syndrome gene which encodes kvlqt1 and its association with mink
09/29/2009	CA2194660C Growth differentiation factor-11
09/29/2009	CA2100329C Methods for treating tumor necrosis factor mediated diseases
09/29/2009	CA1341598C Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex
09/24/2009	WO2009116670A1 Anti-human dlk-1 antibody having anti-tumor activity in vivo
09/24/2009	WO2009116566A1 Industrially useful microorganism
09/24/2009	WO2009116491A1 Monoclonal antibody specifically recognizing human interferon alpha subtype alpha-8 and mutant protein thereof
09/24/2009	WO2009086539A3 Treatment and prophylaxis of amyloidosis
09/24/2009	WO2009055343A3 Fully human anti-vegf antibodies and methods of using

1 ... 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 ... 1125